News / Health

Researchers Develop Antibodies to Treat Ebola Virus

Ebola virusEbola virus
Ebola virus
Ebola virus
Jessica Berman
Researchers say they're making progress toward a treatment for the dreaded Ebola virus, which recently caused outbreaks in equatorial Africa.  Experiments with monkeys using laboratory-engineered disease-fighting agents called monoclonal antibodies show promise in treating infection with the highly lethal disease.

U.S. government and private industry researchers have developed a drug that contains a cocktail of monoclonal antibodies against Ebola. A monoclonal antibody is a disease-fighting protein engineered to target and disarm a specific virus, bypassing natural antibodies produced by the body’s immune system.

Dubbed MB-003, the anti-Ebola cocktail contains three monoclonal antibodies that attach themselves to three different sites on the surface of the deadly virus. The pathogen, unable to evade the multiple attacks, withers away.

Larry Zeitlin is president of Mapp Biopharmaceutical, which helped develop MB-003.  Zeitlin says researchers were originally interested in the monoclonal antibody formulation for bio-defense, should terrorists concoct a biological weapon using Ebola.  But Zeitlin says there is an urgent need for a drug to treat the disease during outbreaks.

In experiments, rhesus macaques were infected with lethal doses of Ebola and then given the monoclonal antibodies up to 48 hours after exposure.  With the treatment, two-thirds of the monkeys survived, according to Zeitlin.

“And one thing we were excited about is the animals showed very little evidence of disease," said Zeitlin.

Ebola causes a sudden onset of severe headache, vomiting, muscle aches, diarrhea, and bleeding. The disease is fatal in up to 90 percent of cases.  

Zeitlin says virologists originally produced the MB-003 proteins in mice, but now use a plant called nicotiana, a relative of tobacco.  By infecting it with portions of the Ebola virus, Zeitlin says nicotiana can be tricked into producing the needed monoclonal antibodies.

“Using these plants, we can manufacture pretty significant quantities of antibody very quickly, much quicker than traditional manufacturing systems.  So if there were an outbreak of Ebola or some new virus, you could rapidly scale up production of antibodies using this system to address that threat," he said.

Zeitlin says researchers hope to move to human safety trials soon, after conducting more animal studies to confirm the antibodies are safe.

It’s not known precisely where the highly infectious virus comes from, but scientists suspect it originated in non-human primates. Outbreaks typically occur every one to two years in the Democratic Republic of Congo, Gabon, Sudan, the Ivory Coast, Uganda, and the Republic of Congo.

An article on the development of plant-derived monoclonal antibodies to treat Ebola is published in the journal Proceedings of the National Academy of Sciences.  

You May Like

800-Pound Man Determined to Slim Down

Man says he was kicked out of hospital for ordering pizza; wants to be an actor More

Australia Prepares to Resettle 12,000 Syrian Refugees

Preference will be given to refugees from persecuted minorities, and the first group is expected to arrive before late December More

S. African Miners Seek Class Action Suit Against Gold Mines

The estimated 100,000 say say they contracted the lung diseases silicosis and tuberculosis in the mines More

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Amnesty Accuses Saudi Coalition of ‘War Crimes’ in Yemeni
Henry Ridgwell
October 12, 2015 4:03 PM
The human rights group Amnesty International has accused the Saudi-led coalition of war crimes in airstrikes against Houthi rebels in Yemen. Henry Ridgwell reports the group says hundreds of civilians have been killed in strikes on residential areas.

Video Amnesty Accuses Saudi Coalition of ‘War Crimes’ in Yemen

The human rights group Amnesty International has accused the Saudi-led coalition of war crimes in airstrikes against Houthi rebels in Yemen. Henry Ridgwell reports the group says hundreds of civilians have been killed in strikes on residential areas.

Video No Resolution in Sight to US House Speaker Drama

Uncertainty grips the U.S. Congress, where no consensus replacement has emerged to succeed Republican House Speaker John Boehner after his surprise resignation announcement. Half of Congress is effectively leaderless weeks before America risks defaulting on its national debt and enduring another partial government shutdown.

Video New Art Exhibit Focuses on Hope

Out of struggle and despair often comes hope. That idea is behind a new art exhibit at the American Visionary Art Museum in Baltimore, Maryland. "The Big Hope Show" features 25 artists, some of whom overcame trauma and loss. VOA’s Deborah Block reports.

Video Columbus Day Still Generates Controversy as US Holiday

The second Monday of October is Columbus Day in the United States, honoring explorer Christopher Columbus and his discovery of the Americas. The achievement is a source of pride for many, but for some the holiday is marked by controversy. Adrianna Zhang has more.

Video Anger Simmers as Turks Begin to Bury Blast Victims

The Turkish army carried out new air strikes on Kurdistan Workers Party (PKK) targets on Sunday, a day after the banned group announced a unilateral cease fire. The air raids apparently are in retaliation for the Saturday bombing in Turkey's capital Ankara that killed at least 95 people and wounded more than 200 others. But as Zlatica Hoke reports, there are suspicions that Islamic State is involved.

Video Bombings a Sign of Turkey’s Deep Troubles

Turkey has begun a three-day period of mourning following Saturday’s bomb attacks in the capital, Ankara, that killed nearly 100 people. With contentious parliamentary elections three weeks away, the attacks highlight the challenges Turkey is facing as it struggles with ethnic friction, an ongoing migrant crisis, and growing tensions with Russia. VOA Europe correspondent Luis Ramirez reports.

Video Afghanistan’s Progress Aided by US Academic Center

Recent combat in Afghanistan has shifted world attention back to the central Asian nation’s continuing civil war and economic challenges. But, while there are many vexing problems facing Afghanistan’s government and people, a group of academics in Omaha, Nebraska has kept a strong faith in the nation’s future through programs to improve education. VOA’s Greg Flakus has more from Omaha, Nebraska.

Video House Republicans in Chaos as Speaker Favorite Withdraws

The Republican widely expected to become the next speaker of the House of Representatives shocked his colleagues Thursday by announcing he was withdrawing his candidacy. The decision by Majority Leader Kevin McCarthy means the race to succeed retiring Speaker John Boehner is now wide open. VOA National Correspondent Jim Malone reports.

Video German, US Officials Investigate Volkswagen

German officials have taken steps to restore some of the reputation their car industry has lost after a recent Volkswagen diesel emissions scandal. Authorities have searched Volkswagen headquarters and other locations in an effort to identify the culprits in the creation of software that helps cheat on emission tests. Meanwhile, a group of lawmakers in Washington held a hearing to get to the bottom of the cheating strategy that was first discovered in the United States. Zlatica Hoke reports.

Video Why Are Gun Laws So Hard for Congress to Tackle?

Since taking office, President Barack Obama has spoken out or issued statements about 15 mass shootings. The most recent shooting, in which 10 people were killed at a community college, sparked outrage over the nation's gun laws. But changing those laws isn't as easy as many think. VOA's Carolyn Presutti reports.

Video In 'He Named Me Malala,' Guggenheim Finds Normal in Extraordinary

Davis Guggenheim’s documentary "He Named Me Malala" offers a probing look into the life of 18-year-old Malala Yousafsai, the Pakistani teenager who, in 2012, was shot in the head by the Taliban for standing up for her right to education in her hometown in Pakistan's Swat Valley. Guggenheim shows how, since then, Malala has become a symbol not as a victim of brutal violence, but as an advocate for girls’ education throughout the world. VOA’s Penelope Poulou has more.

Video Paintable Solar Cells May Someday Replace Silicon-Based Panels

Solar panels today are still factory-manufactured, with the use of some highly toxic substances such as cadmium chloride. But a researcher at St. Mary’s College, Maryland, says we are close to being able to create solar panels by painting them on a suitable surface, using nontoxic solutions. VOA’s George Putic reports.

VOA Blogs